HAV IgM Rapid Test Device (WB/S/P)

Hepatitis A Virus (HAV) is a contagious virus that affects the liver. It commonly spreads through contaminated food, water, or close contact with infected individuals. HAV infection is usually acute and may cause symptoms such as fever, nausea, fatigue, abdominal discomfort, jaundice, and dark urine.

• The HAV IgM Rapid Test Device helps support rapid screening for acute or recent Hepatitis A Virus infection.
• HAV outbreaks may occur through contaminated food, water, poor sanitation, or travel exposure.
• Rapid testing may support early clinical evaluation and infection control workflows.
• HAV IgM antibodies are commonly associated with recent or active immune response to HAV infection.

The HAV IgM Rapid Test Device by LARKSOIS Pharma may be used in professional diagnostic and healthcare screening environments.

Applications

• Acute HAV infection screening
• Recent hepatitis A exposure evaluation
• Travel and outbreak screening support
• Hospital and laboratory infectious disease testing
• Point-of-care diagnostic workflows
• Public health surveillance support
• Community healthcare programs
• Clinical hepatitis screening workflows
• International diagnostic distribution

• The HAV IgM Rapid Test Device works using a lateral flow immunochromatographic assay principle.
• A whole blood, serum, or plasma sample is applied to the test cassette.
• If HAV IgM antibodies are present in the sample, they react with specific test reagents and produce a visible colored line.
• The control line confirms valid sample migration and proper test performance.

The HAV IgM Rapid Test Device uses rapid lateral flow immunochromatographic technology for qualitative detection of HAV IgM antibodies in whole blood, serum, or plasma specimens.

Benefits

• Rapid hepatitis A IgM screening
• Qualitative detection of HAV IgM antibodies
• Suitable for whole blood, serum, or plasma
• Simple visual result interpretation
• Supports outbreak and travel screening workflows
• Useful for clinics, hospitals, and laboratories
• No major laboratory instrument required
• Professional infectious disease diagnostic application

The HAV IgM Rapid Test Device is designed for whole blood, serum, or plasma specimens. Correct specimen collection and handling are important for reliable test performance.

Guidance

• Use approved whole blood, serum, or plasma specimens only
• Collect specimens according to the product insert
• Use clean and suitable sample collection materials
• Avoid contaminated or improperly stored samples
• Apply whole blood, serum, or plasma correctly to the sample well
• Add buffer as instructed
• Read results only within the recommended time window
• Handle all blood specimens as potentially infectious material

Note

Specimen collection, handling, testing, timing, and storage should always follow the official LARKSOIS Pharma kit insert.

The HAV IgM Rapid Test Device by LARKSOIS Pharma is designed for qualitative detection of Hepatitis A Virus IgM antibodies in whole blood, serum, or plasma samples. Detection of HAV IgM antibodies may suggest recent or acute HAV infection.

• HAV IgM antibodies are commonly associated with recent or acute hepatitis A infection.
• Rapid screening may help healthcare professionals evaluate patients with hepatitis-like symptoms.
• The test may support outbreak management, travel-related screening, and public health monitoring.
• Further medical evaluation and laboratory confirmation may be recommended depending on clinical findings.

The HAV IgM Rapid Test Device is a screening aid and should not be used as the only basis for diagnosis or treatment decisions. Results should be interpreted with symptoms, exposure history, vaccination history, and additional laboratory findings.

Instructions

• For professional in-vitro diagnostic use only
• Handle all blood specimens as potentially infectious
• Wear gloves during sample handling
• Do not reuse the test device
• Avoid cross-contamination
• Do not use damaged or expired kits
• Read results only within the recommended time
• Confirm positive results when clinically required

Instructions

• Rapid hepatitis A IgM antibody screening
• Qualitative detection of HAV IgM antibodies
• Suitable for whole blood, serum, or plasma
• Simple visual interpretation
• Supports outbreak and travel screening workflows
• Professional infectious disease application
• Useful for hospitals, clinics, and laboratories
• Practical point-of-care testing support

Note

The HAV IgM Rapid Test Device by LARKSOIS Pharma is designed for professional users who require practical and accessible hepatitis A screening support.

Steps

• Bring the test device, sample, and buffer to room temperature
• Open the sealed pouch only when ready to test
• Place the cassette on a clean and flat surface
• Add whole blood, serum, or plasma to the sample well
• Add buffer according to the instructions for use
• Wait for the recommended reaction time
• Read the test and control lines within the valid time window
• Do not interpret results after the recommended reading time
• Dispose of used materials according to laboratory safety procedures

Note

Testing should be performed by trained healthcare professionals according to the official LARKSOIS Pharma product insert.

Positive

A positive HAV IgM result may suggest recent or acute Hepatitis A Virus infection and should be interpreted with clinical findings.

Negative

A negative result indicates HAV IgM antibodies were not detected at the test sensitivity level.

Invalid

If the control line does not appear, the result is invalid and the test should be repeated with a new device according to the instructions for use.

Instructions

• Store the HAV IgM Rapid Test Device according to the product label and insert
• Store in a cool and dry place
• Keep sealed until use
• Protect from heat, sunlight, and moisture
• Do not freeze unless specified
• Do not use expired kits
• Use immediately after opening the pouch
• Follow all instructions for use carefully

Instructions

• For professional in-vitro diagnostic use only
• Handle all blood specimens carefully
• Wear gloves during sample handling
• Do not reuse the test cassette
• Avoid specimen contamination
• Do not use damaged or expired kits
• Read results only within the recommended time
• Confirm results with clinical evaluation when required

LARKSOIS Pharma provides internationally focused diagnostic products for healthcare professionals, laboratories, clinics, distributors, and public health programs. The HAV IgM Rapid Test Device supports practical, fast, and reliable hepatitis A screening workflows.

Advantages

• International infectious disease rapid test portfolio
• Reliable hepatitis A screening solutions
• Suitable for hospitals, clinics, and laboratories
• Distributor-friendly product support
• Professional healthcare quality standards
• Practical point-of-care diagnostic format
• Export-ready diagnostic product positioning